Literature DB >> 3292076

Cardiopulmonary changes with intermittent endotoxin administration in sheep.

A Godsoe1, R Kimura, D Herndon, J T Flynn, G Schlag, L Traber, D Traber.   

Abstract

Chronic sepsis was induced by administering endotoxin (lipopolysaccharide--LPS) at 12-hr intervals to sheep. The animals (n = 7) responded to the first dose of LPS with increased pulmonary arterial pressure (PAP), systemic vascular resistance, plasma and lymph thromboxane B2 (TxB2) concentrations, and lung lymph flow rate concurrent with a reduction in the cardiac index (CI). Subsequent doses of LPS produced an elevation of PAP and TxB2 which was progressively attenuated and eventually disappeared. With LPS the lung lymph flow was markedly elevated and CI increased. This latter was transient and associated with a reduction in systemic vascular resistance. Concomitant with the cardiopulmonary changes prekallikrein levels were not diminished, but there was a statistically significant reduction in C1-esterase inhibitor. The administration of LPS was discontinued after 5 days and the cardiopulmonary variables rapidly returned to baseline levels. Chronic endotoxemia appears to be associated with an elevated pulmonary microvascular permeability and a tendency toward a hyperdynamic circulation but with an appreciable degree of refractoriness associated with regional hemodynamics and eicosanoid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292076

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  2 in total

1.  In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.

Authors:  S Matsuo; S Ichida; H Takizawa; N Okada; L Baranyi; A Iguchi; B P Morgan; H Okada
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

2.  Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A.

Authors:  Perenlei Enkhbaatar; Christina Nelson; John R Salsbury; Joseph R Carmical; Karen E O Torres; David Herndon; Donald S Prough; Liming Luan; Edward R Sherwood
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.